alpha-aminopyridine has been researched along with Cancer, Embryonal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Albers, P; Becker, TK; Bremmer, F; Calaminus, G; Köhrer, K; Nettersheim, D; Petzsch, P; Schönberger, S; Skowron, MA; Vermeulen, M; Winkelhausen, A | 1 |
Konecny, GE | 1 |
1 review(s) available for alpha-aminopyridine and Cancer, Embryonal
Article | Year |
---|---|
Cyclin-dependent kinase pathways as targets for women's cancer treatment.
Topics: Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Liposarcoma; Lymphoma, Mantle-Cell; Melanoma; Neoplasms, Germ Cell and Embryonal; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Signal Transduction | 2016 |
1 other study(ies) available for alpha-aminopyridine and Cancer, Embryonal
Article | Year |
---|---|
CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms.
Topics: Adult; Aminopyridines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Cisplatin; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasms, Germ Cell and Embryonal; Piperazines; Purines; Pyridines; Sequence Analysis, RNA; Up-Regulation | 2020 |